Dados B3 › CIEL3 × ITSA4
CIEL3 × ITSA4
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CIEL3 | ITSA4 | year |
|---|---|---|---|
| ROE | 18.5% | 18.4% | 2025 |
| ROIC | 8.6% | 18.4%! | 2025 |
| ROA | 2.0% | 14.7% | 2025 |
| Gross margin | 39.6% | 24.4% | 2025 |
| EBIT margin | 21.0% | 219.7%! | 2025 |
| Net margin | 20.8% | 200.6% | 2025 |
| Net debt/EBITDA | 2.27x | 0.25x | 2025 |
| Current ratio | 1.16x | 3.18x | 2025 |
| Revenue growth (1y) | 6.3% | 0.2% | 2025 |
| Revenue growth (5y CAGR) | -0.4% | 7.0% | 2025 |
| Piotroski F-Score | 7/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CIEL3 | ITSA4 | year |
|---|---|---|---|
| P/E | 6.50x | 9.10x | 2023 × 2025 |
| P/B | 1.10x | 1.69x | 2023 × 2025 |
| EV/EBITDA | 4.53x | 7.99x | 2023 × 2025 |
| FCF yield | 3.3% | -0.5% | 2023 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:15 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:15 UTC. If this does not match /saude, you are reading a cached copy.